Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roy M. Fleischmann
Safety, Tolerability, and Pharmacodynamics of ABT-122, a TNF- And IL-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With RA
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8055 in Advanced Solid Tumours and Lymphoma
British Journal of Cancer
Cancer Research
Oncology
Figure 3: Plasma IFN-γ, TNF-α, and IL-17 Levels in Patients With OA.
Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase a in Patients With Fabry Disease
Journal of Inherited Metabolic Disease
Genetics
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/Ii Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
Tolerability and Safety of the Intravenous Immunoglobulin Octagam® 10% in Patients With Immune Thrombocytopenia: A Post-Authorisation Safety Analysis of Two Non-Interventional Phase IV Trials
Hematology
Hematology
Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers
Psychopharmacology
Pharmacology
